Literature DB >> 19780255

Antiemesis clinical practice guidelines in oncology.

David S Ettinger, Philip J Bierman, Bob Bradbury, Georgiana Ellis, Robert J Ignoffo, Steve Kirkegaard, Dwight Kloth, Amy Krauss, Mark G Kris, Dean Lim, Michael Anne Markiewicz, Robert McNulty, Kim Noonan, Lisa Stucky-Marshall, Barbara Todaro, Susan Urba, Sally Yowell.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 19780255     DOI： 10.6004/jnccn.2004.0037

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN： 1540-1405            Impact factor:   11.908


× No keyword cloud information.
  2 in total

1.  Palonosetron plus dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving multiple-day cisplatin chemotherapy for germ cell cancer.

Authors:  Lawrence H Einhorn; Mary J Brames; Robert Dreicer; Craig R Nichols; Michael T Cullen; Joseph Bubalo
Journal:  Support Care Cancer       Date:  2007-04-14       Impact factor: 3.603

2.  Oral ondansetron is highly active as rescue antiemetic treatment for moderately emetogenic chemotherapy: results of a randomized phase II study.

Authors:  Alessandra Fabi; Mariangela Ciccarese; Giulio Metro; Antonella Savarese; Diana Giannarelli; Carmen M Nuzzo; Michelangelo Russillo; Isabella Sperduti; Ilaria Carbone; Emilio Bria; Francesco Cognetti
Journal:  Support Care Cancer       Date:  2008-05-14       Impact factor: 3.603
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.